LONDON, Aug. 31, 2017 /PRNewswire/ -- Rising incidences of Pediatric cancer has provoked medical organizations towards development and implementation of sophisticated treatment procedures, which is "Proton Radiotherapy". The efficiency of proton therapy continues to add trust of Pediatric cancer patients globally. The course of action is known for successfully destructing tumor cells by damaging their DNA during a targeted deposition of high-energy radiation dosage onto the tumor.
Globally the Pediatric cancer cases are increasing rapidly at a great pace. Global Pediatric Proton Therapy Market has potential of more than US$ 700 Million by 2021. United States dominates the proton therapy centers in the world because of its huge investment in the development of therapy centers as well as its elongated history of proton therapy.
USA leads the Pediatric Proton Therapy Market globally
Ad Statistics
Times Displayed: 112448
Times Visited: 6718 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
USA has the highest pediatric proton therapy market share but gradually it will lose its market share in future, due to stiff competition from Germany, France, United Kingdom and Japan. This report provides the data on USA Pediatric Proton Therapy Market & Patients numbers, in 36 Cancer Types. Out of these 36 cancer types approximately, 15 percent of market share is taken by Ependymoma cancerous tumor.
United States Age Group of (1-4) has the highest Cancer Evidence in Pediatric Proton Therapy Market
The report captures the USA pediatric proton therapy market data on five age groups (<1) Year, (1-4) Year, (5-9) Year, (10-14) Year, (15-18) Year. In these age groups (1-4) Year has highest market. >
United Kingdom, France and Germany is driving the Europe Pediatric Proton Therapy Market
Growing number of cancer diagnosed pediatric patients in Europe will enforce the many countries in Europe to expand proton therapy centers because of the demand. Improvement in Technology is playing a very crucial role in driving pediatric proton therapy market in Europe. Germany leads the pediatric proton therapy market in Europe. In 2010, France had the maximum market share of Pediatric Proton Therapy. Other countries studied in the reports are Switzerland, Czech Republic, Sweden, and United Kingdom.
Japan & China along with South Korea drives the Proton Therapy Market in Asia
Pediatric Proton therapy technology has immense potential as it is evident from the increasing number of proton therapy centers across Asia. Japan has already established their benchmark for the treatment of pediatric patient with proton therapy. China is more focused toward developing 8 proton therapy centers (Under-construction + Planning Phase) to serve their massive population.
